论文部分内容阅读
目的观察心肝宝胶囊对慢性乙型肝炎患者血清肝纤维化指标的临床治疗效果。方法将90例慢性乙型肝炎患者随机分为治疗组和对照组,观察治疗结束后两组血清肝纤维化指标的变化。结果在治疗组血清肝纤维化指标明显改善,与对照组相比有显著性差异。结论心肝宝胶囊有减轻肝损伤促使血清ALT复常的作用。尤其是可以降低血清肝纤维化指标水平,可以达到减轻和抑制肝纤维化形成的作用,值得临床应用。
Objective To observe the clinical effect of Xinganbao Capsule on serum fibrosis in patients with chronic hepatitis B. Methods Ninety patients with chronic hepatitis B were randomly divided into treatment group and control group. Changes of serum fibrosis indexes were observed after treatment. Results Serum hepatic fibrosis was significantly improved in the treatment group, which was significantly different from the control group. Conclusion Xinganbao Capsule can relieve liver injury and promote serum ALT function. In particular, it can reduce serum hepatic fibrosis index levels, can reduce and inhibit the formation of liver fibrosis, and is worthy of clinical application.